Black Diamond Therapeutics, Inc. · NASDAQ:BDTX

BlackRock, Inc. reported a 6.70% stake in Black Diamond Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Jul 27, 2026

BlackRock, Inc. reported a 6.70% stake in Black Diamond Therapeutics, Inc., 3,838,590 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G).

Stake
6.70%
Shares
3,838,590
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.6.70%3,838,590

Source

View original at SEC

Related